NCMAG121 Nivolumab in combination with ipilimumab Advice Document
Posted on:
Document Type
NCMAG advice
Process guidance
Summary
Nivolumab in combination with ipilimumab for the neoadjuvant treatment of
resectable stage III melanoma
Decision: Supported